Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Non-Current ReceivablesReceivables - NetReceivables - OtherReceivables Refunds
Ratios

Ascendis Pharma A (ASND) Receivables Refunds (2016 - 2025)

Ascendis Pharma A's Receivables Refunds history spans 7 years, with the latest figure at $862903.8 for Q4 2023.

  • For Q4 2023, Receivables Refunds fell 4.22% year-over-year to $862903.8; the TTM value through Dec 2023 reached $862903.8, down 4.22%, while the annual FY2023 figure was $867537.5, 6.78% down from the prior year.
  • Receivables Refunds for Q4 2023 was $862903.8 at Ascendis Pharma A, down from $900878.4 in the prior quarter.
  • Across five years, Receivables Refunds topped out at $1.6 million in Q4 2019 and bottomed at $862903.8 in Q4 2023.
  • The 4-year median for Receivables Refunds is $961222.2 (2021), against an average of $1.1 million.
  • The largest annual shift saw Receivables Refunds soared 68.25% in 2019 before it decreased 11.81% in 2022.
  • A 4-year view of Receivables Refunds shows it stood at $1.6 million in 2019, then tumbled by 37.34% to $1.0 million in 2021, then dropped by 11.81% to $900878.4 in 2022, then dropped by 4.22% to $862903.8 in 2023.
  • Per Business Quant, the three most recent readings for ASND's Receivables Refunds are $862903.8 (Q4 2023), $900878.4 (Q4 2022), and $1.0 million (Q4 2021).